 |
 |
 |
|
 |
|
 |
 |
 |
 |
 |
Herz-Kreislauf > Antikoagulation und Fibrinolytika > Thrombozytenhemmer > Glykoprotein IIb/IIIa-Antagonisten
Abciximab
|
| |||||||||||
|
| Herz-Kreislauf > Antikoagulation und Fibrinolytika > Thrombozytenhemmer > Glykoprotein IIb/IIIa-Antagonisten |
|||||||||||
|
Abciximab
|
||||||||||||
|
| Editorial | ||
Substanzgruppe |
|
|
 |
||
Autor |
||
|
||
Erstellt |
29.03.2003 |
|
|
||
Reviewer |
||
|
||
Status |
TRACK2 |
|
|
||
Licence |
||
|
||
| ||||||||||
